Neuromark (system of treatment of chronic cold)

2021: The announcement of Neuromark - the system of treatment of chronic cold

At the beginning of February, 2021 the Irish company Neurent Medical submitted the Neuromark system for out-patient treatment of chronic rhinitis. Unlike pharmacological methods of treatment, this system influences the nervous terminations responsible for many general symptoms of rhinitis, such as congestion of a nose.

Chronic rhinitis is an inflammatory damage of a mucous membrane of a nose which leads to development of resistant symptoms and considerably reduces quality of life, mood and daily activity. Pharmacological treatment helps not all patients, and surgical interventions can provide partial and short-term simplification, but are connected with certain risks and complications.

A system for out-patient treatment of chronic cold of Neuromark is released

The Neuromark system was developed for out-patient treatment of not allergic rhinitis under local anesthesia. By means of a neyroliz a system destroys the hardly accessible hyperactive parasympathetic terminations which cause congestion of a nose and rinoreyu, but at the same time saves integrity of adjacent tissues of nose. A system allows doctors to influence several nervous segments during one procedure at once, and special algorithms define a therapy limit. A system automatically chooses the necessary volume of treatment for each patient, reducing risk of damage of fabrics and increasing efficiency.

According to developers, therapy can be carried out easily for one procedure in the ENT specialist's office using only local anesthetic that allows the patient to return to normal life immediately. At the same time algorithms of RNT and monitoring of a biological feedback ensure safety of the procedure, controlling parameters of fabrics, arrangement and duration of influence. It prevents both excessive damage of fabrics, and inefficiency of the procedure at insufficient impact on the nervous terminations.^[1]

Notes